StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.61+0.00 (+0.19%)

Close on Nov 13, 2026Market cap $2.92MP/E –Yield –

Bluejay Diagnostics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Bluejay Diagnostics's enterprise value was -$4.04M on Nov 11, 2026, against $5.44M a year earlier. Over the last 5 years it ranged from -$7.90M to $105.48M, with a median of $3.96M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$4.04M–
2025Dec 31, 2025-$1.99M-267.1%
2024Dec 31, 2024$1.19M+23.1%
2023Dec 29, 2023$966.46K-94.4%
2022Dec 30, 2022$17.35M-83.6%
2021Dec 31, 2021$105.48M–

More Bluejay Diagnostics figures

See a number that looks wrong?